Public Profile

Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States, with significant operations across Europe, Asia, and other regions. Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, Limited, the company has established itself as a leader in innovative medicines, particularly in oncology, cardiovascular, and vaccine development. Daiichi Sankyo is renowned for its unique approach to drug discovery and development, leveraging advanced technologies to create targeted therapies. Its core products, including the groundbreaking cancer treatment, have positioned the company as a key competitor in the pharmaceutical market. With a commitment to improving patient outcomes, Daiichi Sankyo continues to achieve notable milestones, solidifying its reputation as a trusted name in healthcare.

DitchCarbon Score

How does Daiichi Sankyo, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

37

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Daiichi Sankyo, Inc.'s score of 37 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

70%

Let us know if this data was useful to you

Daiichi Sankyo, Inc.'s reported carbon emissions

Daiichi Sankyo, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current carbon footprint or progress in addressing climate change. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing greenhouse gas emissions, indicating a broader commitment to environmental responsibility. As such, Daiichi Sankyo may be engaging in internal strategies to align with industry standards, although specific details are not disclosed.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Daiichi Sankyo, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Daiichi Sankyo, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Daiichi Sankyo, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

American Regent, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

TG Therapeutics, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Zogenix, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Shandong New Time Pharmaceutical Co., Ltd.

CN
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers